Published in Int J Endocrinol on May 19, 2015
Changes in Type 2 Diabetes Mellitus Patients in German Primary Care Prior to (2006) and After (2010, 2014) Launch of New Drugs. J Diabetes Sci Technol (2016) 0.82
Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review. Curr Ther Res Clin Exp (2017) 0.75
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care (2012) 21.62
Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med (2007) 4.20
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Care (2007) 3.56
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care (2004) 3.31
The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care (2002) 2.83
A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Curr Med Res Opin (2011) 1.79
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. J Clin Endocrinol Metab (2007) 1.70
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin. Diabetes Obes Metab (2011) 1.38
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus. Diabetes Obes Metab (2009) 1.28
Fixed-dose combinations for treatment of type 2 diabetes mellitus. Adv Ther (2012) 1.09
An overview of management issues in adult patients with type 2 diabetes mellitus. J Diabetes Sci Technol (2011) 0.90
Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries. Eur J Prev Cardiol (2012) 0.89
Effect of vildagliptin as add-on therapy to a low-dose metformin. World J Diabetes (2010) 0.88
Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis. Curr Med Res Opin (2012) 0.88